NEWS

 

News from Simsen.


New partnerships and study collaborations, the events where you'll find us, and our thinking on tumour-informed ctDNA and where it's taking cancer care.
5 min read

From more treatment to smarter treatment: how tumour‑informed ctDNA monitoring can reduce harm and free capacity in cancer care

Dec 17, 2025

Cancer services across the Nordics are under familiar pressure: rising incidence, tighter staffing, constrained imaging...
2 min read

Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial

Nov 17, 2025

Simsen Diagnostics Partners with One-carbon Therapeutics for Groundbreaking ODIN Cancer Trial Simsen Diagnostics, a...
3 min read

How Pharma Companies Can Leverage Simsen Diagnostic’s Tumour-Informed ctDNA Analysis to Transform Cancer Drug Trials

Nov 11, 2025

Developing effective cancer treatments is one of the most challenging frontiers in drug development, where precision,...
1 min read

Simsen Diagnostics to Present at GoCo Investor Day, Autumn 2025

Jul 9, 2025

Simsen Diagnostics is excited to announce our participation in the upcoming GoCo Investor Day, a leading gathering for...
1 min read

Simsen Diagnostics' hospital laboratory solution

Jun 26, 2025

We are proud to announce a new partnership with a Swedish hospital, paving the way for transformative advancements in...
1 min read

Simsen Diagnostics to Attend Ecosystem Exchange: Life Sciences 2025

Apr 14, 2025

We are pleased to announce that our CEO, Pontus Rehn, will represent Simsen Diagnostics at the upcoming Ecosystem...
1 min read

Simsen will attend the Swiss Nordic Bio 2025

Feb 26, 2025

Simsen Diagnostics is excited to announce its participation in the upcoming Swiss Nordic Bio 2025 conference, which...
2 min read

Simsen announces collaboration with Buzzard Pharmaceuticals

Feb 21, 2025

Gothenburg, 21 February 2025 Simsen Diagnostics Partners with Buzzard Pharmaceuticals for Isunakinra Colorectal Cancer...
2 min read

Simsen Diagnostics Announces Collaboration with Private Cancer Center Docrates

Oct 25, 2024

Gothenburg 2024-10-25: Simsen Diagnostics has signed an agreement with Docrates, a private cancer center in Finland....
3 min read

Interview with Ola Nilsson, Neogap Therapeutics

Sep 27, 2024

A few weeks ago, we had the opportunity to meet with Ola Nilsson, Head of Neoantigen Production & Development at Neogap...
2 min read

Mid-Year Summary 2024

Jul 12, 2024

As we approach summer and vacations (at least for some of us in the office and most industry people here in Sweden), we...
2 min read

Simsen Diagnostics and Orion Corporation Announce Collaboration for Phase I Study

Jun 26, 2024

Gothenburg, 2024-06-26 – Simsen Diagnostics is announcing a new exciting collaboration with Orion Corporation, a...
 
 
 
 
TALK TO US
 

Speak to the scientist, not a queue.

Tell us about your trial, your patients, or your lab, and we will point you to the right person here.